Cargando…
Public healthcare expenditure and COVID-19 mortality in Spain and in Europe()
OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autono...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133611/ https://www.ncbi.nlm.nih.gov/pubmed/34049840 http://dx.doi.org/10.1016/j.rceng.2020.11.006 |
_version_ | 1783695096640700416 |
---|---|
author | Elola-Somoza, F.J. Bas-Villalobos, M.C. Pérez-Villacastín, J. Macaya-Miguel, C. |
author_facet | Elola-Somoza, F.J. Bas-Villalobos, M.C. Pérez-Villacastín, J. Macaya-Miguel, C. |
author_sort | Elola-Somoza, F.J. |
collection | PubMed |
description | OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. RESULTS: No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain’s Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. CONCLUSIONS: The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency. |
format | Online Article Text |
id | pubmed-8133611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). |
record_format | MEDLINE/PubMed |
spelling | pubmed-81336112021-05-20 Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() Elola-Somoza, F.J. Bas-Villalobos, M.C. Pérez-Villacastín, J. Macaya-Miguel, C. Rev Clin Esp (Barc) Brief Original OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. RESULTS: No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain’s Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. CONCLUSIONS: The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency. Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2021 2021-05-19 /pmc/articles/PMC8133611/ /pubmed/34049840 http://dx.doi.org/10.1016/j.rceng.2020.11.006 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Original Elola-Somoza, F.J. Bas-Villalobos, M.C. Pérez-Villacastín, J. Macaya-Miguel, C. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() |
title | Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() |
title_full | Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() |
title_fullStr | Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() |
title_full_unstemmed | Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() |
title_short | Public healthcare expenditure and COVID-19 mortality in Spain and in Europe() |
title_sort | public healthcare expenditure and covid-19 mortality in spain and in europe() |
topic | Brief Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133611/ https://www.ncbi.nlm.nih.gov/pubmed/34049840 http://dx.doi.org/10.1016/j.rceng.2020.11.006 |
work_keys_str_mv | AT elolasomozafj publichealthcareexpenditureandcovid19mortalityinspainandineurope AT basvillalobosmc publichealthcareexpenditureandcovid19mortalityinspainandineurope AT perezvillacastinj publichealthcareexpenditureandcovid19mortalityinspainandineurope AT macayamiguelc publichealthcareexpenditureandcovid19mortalityinspainandineurope |